Avenue Therapeutics, Inc. (ATXI) NASDAQ

0.60

+0.0537(+9.83%)

Updated at August 18 03:30PM

Currency In USD

Valuation

Market Cap25.9M
Enterprise Value23.31M
P/E Ratio-0.13
PEG Ratio-0
Price/Sales Ratio0
Price/Book Ratio0.51
Enterprise/Revenue0
Enterprise/EBITDA0.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-3.8
Return On Equity-3.99

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-11.28M
Net Income-11.65M
Diluted EPS-0.9

Balance Sheet

Total Cash3.5M
Total Cash/Share1.18
Total Debt0
Total Debt/Equity0
Current Ratio2.85
Book Value Per Share0.78

Price History

52-Week Change-79.45
52-Week High3.54
52-Week Low0.17
Moving Average 50 Days0.35
Moving Average 200 Days0.91

Statistics

Average Volume8,332
Shares Outstanding3.18M
% Held by Institutions1.12

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:75
Last Split DateApril 26, 2024